← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Beam Diagnostics, Inc.
Roanoke, VA
$5,670,978
Total funding
5
Grants
Funding over time
peak $1.7M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,670,978 · 5
By mechanism
R44$1,838,434 · 1
R42$1,682,545 · 1
SB1$1,651,213 · 1
R41$498,786 · 2
Investigators at Beam Diagnostics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Achieving FDA Approval & Commercial Readiness for Beacon-AUD: A Digital Diagnostic Medical Device for Alcohol Use Disorder$1,651,213
SB1 · FY2025 · AA
Beacon-OUD: Behavioral Economic Screening Tool of Opioid Use Disorder for Use in Clinical Practice$935,721
R44 · FY2024 · DA
Beacon-OUD: Behavioral Economic Screening Tool of Opioid Use Disorder for Use in Clinical Practice$902,713
R44 · FY2023 · DA
Technology transfer of behavioral economic tasks for assessing alcohol reinforcer pathology: Development and feasibility of a commercially-available tool for clinical practice$853,388
R42 · FY2022 · AA
Technology transfer of behavioral economic tasks for assessing alcohol reinforcer pathology: Development and feasibility of a commercially-available tool for clinical practice$829,157
R42 · FY2021 · AA
Technology transfer of behavioral economic tasks for assessing alcohol reinforcer pathology: Development and feasibility of a commercially-available tool for clinical practice$285,003
R41 · FY2018 · AA
BEST-OUD: Behavioral Economic Screening Tool of Opioid Use Disorder for use in clinical practice$213,783
R41 · FY2019 · DA